BMI1 and breast carcinoma: On the other hand, we noted that the diagnostic efficiency of the autoantibody panel comprising BMI-1, HSP70, NY-ESO-1 and p53 autoantibodies for early stage breast cancer was similar with other optimized autoantibody panels identified for early stage esophagogastric junction adenocarcinoma and esophageal squamous cell carcinoma 16, 17.